Novel Compounds as CDK4 Inhibitors for Treating Breast Cancer

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis
DOI: 10.1021/acsmedchemlett.6c00286
Cited by: 1
References: 6

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel compounds as CDK4 inhibitors, pharmaceutical compositions, use of such compounds in treating breast cancer, and processes for preparing such compounds.

Fields of Study & Subjects

Advanced Breast Cancer Therapies Cancer-related Molecular Pathways Synthesis and Reactivity of Heterocycles

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
7
Pages
1464–1465
Publication date
8 June 2026
Language
EN